The researchers attempted to shuttle miR-139 into CAFs to increase their bioavailability to gastric cancer cell lines in vitro and to stomach tumors in vivo, and found that both experiments resulted in drastic decreases in MMP11 expression. Here, MMP11 is linked to gastric cancer.